Evidence map›Paper›PMID 34782236›Full record

ReviewTrends in endocrinology and metabolism: TEM2022

Hexokinase domain-containing protein-1 in metabolic diseases and beyond.

Joseph L Zapater, Kristen R Lednovich, Md Wasim Khan, Carolina M Pusec, Brian T Layden

Open access · hybridAbstract readReview
In one paragraph

Review in Trends in endocrinology and metabolism: TEM, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 58 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. The moonlighting functions of glycolytic enzymes in tumorigenesis.Cellular oncology (Dordrecht, Netherlands) · 2026
    Review
  7. Impact ofArchives of medical science : AMS · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Hypoxia-inducible factor-1 as targets for neuroprotection : from ferroptosis to Parkinson's disease.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Joseph L ZapaterDivision of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA; Jesse Brown VA Medical Center, Chicago, IL, USA.
Kristen R LednovichDivision of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA.
Md Wasim KhanDivision of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA.
Carolina M PusecDivision of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA.
Brian T LaydenDivision of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA; Jesse Brown VA Medical Center, Chicago, IL, USA. Electronic address: blayde1@uic.edu.
University of Illinois Chicago · US

Funding

The function and regulation of the novel pregnancy-specific hexokinase HKDC1R01DK104927 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI LAYDEN, BRIAN THOMAS, REDDY, TIMOTHY E · 2015 to 2024
$7.2M
UIC Diabetes Research Training ProgramT32DK128782 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI UNTERMAN, TERRY G. · 2021 to 2025
$957k
Role of Nutrient Sensing Receptors for the Gut Microbiota in MetabolismI01BX003382 · VA · JESSE BROWN VA MEDICAL CENTER · PI LAYDEN, BRIAN THOMAS · 2017 to 2025
–
BLRD VA I01 BX003382NIDDK NIH HHS R01 DK104927NIDDK NIH HHS T32 DK128782
6 · The paper itself

Abstract

Glucose phosphorylation by hexokinases (HKs) traps glucose in cells and facilitates its usage in metabolic processes dependent on cellular needs. HK domain-containing protein-1 (HKDC1) is a recently discovered protein with wide expression containing HK activity, first noted through a genome-wide association study (GWAS) to be linked with gestational glucose homeostasis during pregnancy. Since then, HKDC1 has been observed to be expressed in many human tissues. Moreover, studies have shown that HKDC1 plays a role in glucose homeostasis by which it may affect the progression of many pathophysiological conditions such as gestational diabetes mellitus (GDM), nonalcoholic steatohepatitis (NASH), and cancer. Here, we review the key studies contributing to our current understanding of the roles of HKDC1 in human pathophysiological conditions and potential therapeutic interventions.

Indexed as

Diabetes, GestationalNon-alcoholic Fatty Liver DiseaseFemaleGenome-Wide Association StudyGlucoseHexokinaseHumansPregnancyGlucoseHexokinasecancerglucose metabolismhexokinaseHKDC1

Identifiers

PMID34782236
PMCPMC8678314
OpenAlexW3212992100

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.